Strategy, advice, and inspiration for digital marketing and social media experts

Pharma Marketing Trends 2024: Navigating a Dynamic Digital Landscape

February 14, 2024
Posted by: Rishi Kadiwar, VP Strategy- DTC

The pharmaceutical industry faces a shifting landscape in 2024, as the ‘COVID halo effect’ wanes. Past accolades for innovation must now be translated into sustained trust. This blog explores trends guiding pharma marketers to be more audience-centric and connect with patients, caregivers, and healthcare professionals in the post-pandemic era.    Trend 1: Short Form Video […]

Read more

10 Pharma Marketing Factors Shaping 2024

January 12, 2024
Posted by: Danny Flamberg, VP Strategy- HCP

As the new year dawns, consider these 10 factors that will influence and affect healthcare and pharma marketing over the next 12 months. Social is Soaring. Social media has become the channel of choice for most patients, caregivers, and HCP segments. Social media has established itself as part of physicians’ daily clinical toolkit. Social commerce […]

Read more

Comparing Celebrity and Micro-Influencers for Pharma Marketing Brands

October 24, 2023
Posted by: Rishi Kadiwar, VP Strategy- DTC

Pfizer did not start the celebrity influencer trend, but it sure has capitalized on it.  From former U.S. Senator, Bob Dole: partnering with Pfizer for its erectile dysfunction drug Viagra in the late 1990s to NFL player Travis Kelce (and Taylor Swift’s current boyfriend) educating fans about the importance of getting their COVID and flu […]

Read more

Healthcare Pros Demand Tailored Pharma Data

September 20, 2023
Posted by: Danny Flamberg, VP Strategy- HCP

HCPs want personalized multi-dimensional pre-packaged messaging from pharma. That’s the key takeaway from Precisionxtract’s 2023 HCP Annual Insights Report which surveyed 100 actively practicing physicians who see an average of 116 patients each week. For most HCPs efficacy data for new medications or new treatment options isn’t enough to drive a change in prescribing behavior. […]

Read more